Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NextGate is a global leader in healthcare identity management, specializing in Enterprise Master Patient Index (EMPI) and Master Data Management (MDM) solutions. The company's flagship MatchMetrix platform provides a cloud-based framework for accurately identifying and linking patient data across disparate healthcare IT systems. By resolving identity mismatches and reducing duplicate records, NextGate facilitates seamless data exchange and improves the quality of care. The company serves a wide range of clients, including health systems, health information exchanges (HIEs), and health plans. In July 2022, NextGate was acquired by Lyniate (now Rhapsody) to bolster its interoperability and data integration capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NextGate.